ABL Bio
Latest round
- Series C
Last raised
- Jun 2018
Total raised
- $90M
Investors
- 15
About ABL Bio
Established in 2016 and based in Gyeonggi-Do, South Korea, ABL Bio, Inc. is a biotechnology research firm developing therapeutic drugs for immuno-oncology & neurodegenerative diseases. In January 2026, ABL Bio, Inc.
Who invested in ABL Bio
15 investors across 3 rounds
See all investors in ABL Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ABL Bio
Who invested in ABL Bio?
ABL Bio has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ABL Bio raised?
ABL Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ABL Bio last raise money?
ABL Bio's most recent round on record is a Series C, in Jun 2018.
What does ABL Bio do?
Established in 2016 and based in Gyeonggi-Do, South Korea, ABL Bio, Inc.
Where is ABL Bio headquartered?
ABL Bio is headquartered in Seoul, South Korea.
Which VCs invest in companies like ABL Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ABL Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like ABL Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.